Form 4 for TECH Bio-Techne
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-01 · accession 0000914190-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-02-01 | TECH | McManus Matthew | Pres - Diag, Spatial Bio | M - OptEx | $0.00 | +4,621 | 9,356 | +98% | $0 |
| D | 2026-02-03 | 2026-02-01 | TECH | McManus Matthew | Pres - Diag, Spatial Bio | F - Tax | $64.09 | -1,665 | 7,691 | -18% | -$106.7K |
| D | 2026-02-03 | 2026-02-01 | TECH | McManus Matthew | Pres - Diag, Spatial Bio | M - OptEx | $0.00 | -4,621 | 4,620 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-01 | M | A | 4,621 | $0.00 | 9,356 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-01 | F | D | 1,665 | $64.09 | 7,691 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-02-01 | M | D | 4,621 | $0.00 | 4,620 | D | — · — to — | 4,621 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F3) 4,621 restricted stock units vest on 2/1/2026 and 4,620 restricted stock units vest on 2/1/2027. |